Financhill
Back

Recursion Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Recursion Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.09 Sell
20-day SMA: 4.45 Sell
50-day SMA: 4.46 Sell
200-day SMA: 4.98 Sell
8-day EMA: 3.06 Buy
20-day EMA: 1.79 Buy
50-day EMA: 0.85 Buy
200-day EMA: 0.23 Buy

Recursion Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.03 Buy
Relative Strength Index (14 RSI): 41.95 Sell
Chaikin Money Flow: 19903841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.12 - 4.8) Sell
Bollinger Bands (100): (4.17 - 5.47) Sell

Recursion Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Recursion Pharmaceuticals, Inc. Stock

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

RXRX Technical Analysis vs Fundamental Analysis

Sell
11
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Is Recursion Pharmaceuticals, Inc. a Buy or a Sell?

Recursion Pharmaceuticals, Inc. Stock Info

Market Cap:
2.1B
Price in USD:
3.98
Share Volume:
26.3M

Recursion Pharmaceuticals, Inc. 52-Week Range

52-Week High:
12.36
52-Week Low:
3.54
Sell
11
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Recursion Pharmaceuticals, Inc. Share Price Forecast

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Recursion Pharmaceuticals, Inc.

Is Recursion Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.23 per share.

Technical Analysis of Recursion Pharmaceuticals, Inc.

Should I short Recursion Pharmaceuticals, Inc. stock?

* Recursion Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.